These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 11507078

  • 21. TGF-beta-induced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor.
    Qureshi HY, Sylvester J, El Mabrouk M, Zafarullah M.
    J Cell Physiol; 2005 May; 203(2):345-52. PubMed ID: 15468069
    [Abstract] [Full Text] [Related]

  • 22. Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition.
    Baldwin RL, Friess H, Yokoyama M, Lopez ME, Kobrin MS, Büchler MW, Korc M.
    Int J Cancer; 1996 Jul 17; 67(2):283-8. PubMed ID: 8760600
    [Abstract] [Full Text] [Related]

  • 23. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.
    Lee BI, Park SH, Kim JW, Sausville EA, Kim HT, Nakanishi O, Trepel JB, Kim SJ.
    Cancer Res; 2001 Feb 01; 61(3):931-4. PubMed ID: 11221885
    [Abstract] [Full Text] [Related]

  • 24. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.
    Nair PN, De Armond DT, Adamo ML, Strodel WE, Freeman JW.
    Oncogene; 2001 Dec 13; 20(57):8203-14. PubMed ID: 11781836
    [Abstract] [Full Text] [Related]

  • 25. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB, Moody TW, Mariano JM.
    Anticancer Res; 1997 Dec 13; 17(3C):1849-60. PubMed ID: 9216635
    [Abstract] [Full Text] [Related]

  • 26. Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines.
    Hougaard S, Nørgaard P, Abrahamsen N, Moses HL, Spang-Thomsen M, Skovgaard Poulsen H.
    Br J Cancer; 1999 Mar 13; 79(7-8):1005-11. PubMed ID: 10098728
    [Abstract] [Full Text] [Related]

  • 27. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
    Zhu ZW, Friess H, Wang L, Bogardus T, Korc M, Kleeff J, Büchler MW.
    Clin Cancer Res; 2001 Jan 13; 7(1):105-12. PubMed ID: 11205897
    [Abstract] [Full Text] [Related]

  • 28. Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells.
    Yang HK, Kang SH, Kim YS, Won K, Bang YJ, Kim SJ.
    Oncogene; 1999 Apr 01; 18(13):2213-9. PubMed ID: 10327067
    [Abstract] [Full Text] [Related]

  • 29. Cell type-specific regulation of the TGF-beta-responsive alpha2(I) collagen gene by CpG methylation.
    Yamane K, Suzuki H, Ihn H, Kato M, Yoshikawa H, Tamaki K.
    J Cell Physiol; 2005 Mar 01; 202(3):822-30. PubMed ID: 15389632
    [Abstract] [Full Text] [Related]

  • 30. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer.
    Zhao H, Shiina H, Greene KL, Li LC, Tanaka Y, Kishi H, Igawa M, Kane CJ, Carroll P, Dahiya R.
    Cancer; 2005 Jul 01; 104(1):44-52. PubMed ID: 15895377
    [Abstract] [Full Text] [Related]

  • 31. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H, Tatematsu Y, Masuda A, Saito T, Sugiyama M, Yanagisawa K, Takahashi T.
    Cancer Res; 2001 Nov 15; 61(22):8331-9. PubMed ID: 11719467
    [Abstract] [Full Text] [Related]

  • 32. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.
    Grau AM, Zhang L, Wang W, Ruan S, Evans DB, Abbruzzese JL, Zhang W, Chiao PJ.
    Cancer Res; 1997 Sep 15; 57(18):3929-34. PubMed ID: 9307274
    [Abstract] [Full Text] [Related]

  • 33. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K, Yamashita H, Mogi A, Takenoshita S, Miyazono K.
    J Cell Physiol; 1998 Jun 15; 175(3):305-13. PubMed ID: 9572475
    [Abstract] [Full Text] [Related]

  • 34. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
    Huang W, Zhao S, Ammanamanchi S, Brattain M, Venkatasubbarao K, Freeman JW.
    J Biol Chem; 2005 Mar 18; 280(11):10047-54. PubMed ID: 15647279
    [Abstract] [Full Text] [Related]

  • 35. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
    Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K.
    Oncogene; 2004 Mar 04; 23(9):1656-67. PubMed ID: 15001984
    [Abstract] [Full Text] [Related]

  • 36. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
    Rowland-Goldsmith MA, Maruyama H, Kusama T, Ralli S, Korc M.
    Clin Cancer Res; 2001 Sep 04; 7(9):2931-40. PubMed ID: 11555612
    [Abstract] [Full Text] [Related]

  • 37. Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells.
    Jungert K, Buck A, Buchholz M, Wagner M, Adler G, Gress TM, Ellenrieder V.
    Carcinogenesis; 2006 Dec 04; 27(12):2392-401. PubMed ID: 16714330
    [Abstract] [Full Text] [Related]

  • 38. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
    Miyafuji Y, Zhong X, Uchida I, Koi M, Hemmi H.
    J Cell Physiol; 2001 Jun 04; 187(3):356-64. PubMed ID: 11319759
    [Abstract] [Full Text] [Related]

  • 39. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma.
    Shi Q, Le X, Abbruzzese JL, Peng Z, Qian CN, Tang H, Xiong Q, Wang B, Li XC, Xie K.
    Cancer Res; 2001 May 15; 61(10):4143-54. PubMed ID: 11358838
    [Abstract] [Full Text] [Related]

  • 40. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y, Kyprianou N.
    Cell Growth Differ; 1998 Feb 15; 9(2):185-93. PubMed ID: 9486855
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.